Skip to content

Author

En-Yong Dai

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Clinical characteristics of immune-related adverse events after immune checkpoint inhibitor therapy with or without chemotherapy in patients with antinuclear antibody-positive malignancies

Background Antinuclear antibodies (ANA) are detected in cancer patients before ICI therapy, but their association with immune-related adverse events (irAEs) and outcomes is uncertain. This study aimed to characterize irAEs and tolerability in ANA-positive patients receiving ICI ± chemotherapy, and explore implications...

Hang-Hui Yu, En-Yong Dai, Jian-Peng Xing et al. · 0 citations
Review Open access Sep 2026

Phase Separation, Material State, and Condensate Fate in Mammalian Autophagy

Biomolecular phase separation has emerged as a key organizing principle in macroautophagy (hereafter autophagy). In mammalian cells, phase‐separated condensates not only serve as substrates for selective degradation, but also act as dynamic platforms for cargo recognition, signaling integration, and autophagosome assem...

Yuan-Qiang Lin, Mingran Dai, En-Yong Dai et al. · 0 citations
Sep 2026

Non-canonical Wnt11/PCP/YAP signaling mediates epithelial-mesenchymal transition and immunosuppressive tumor microenvironment in colorectal cancer.

The Wnt11/PCP/YAP axis is identified as a dual driver of CRC malignant progression and immune evasion, providing a mechanistic basis for targeted therapies and immunotherapy combination strategies.

Shi-Bao Wang, Heng-Yu Cai, En-Yong Dai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.